Twin Tree Management, LP Astrazeneca PLC Call Options Transaction History

Twin Tree Management, LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $10.4 Million - $11.9 Million	170,400 New	170,400 $11.5 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $42.6 Million - $51.1 Million	-718,800 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $31.1 Million - $37.5 Million	559,000 Added 349.81%	718,800 $47.7 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $10.7 Million - $11.7 Million	-193,200 Reduced 54.73%	159,800 $9.6 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $8.04 Million - $9.28 Million	170,500 Added 93.42%	353,000 $17.6 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $1.32 Million - $1.43 Million	-41,200 Reduced 18.42%	182,500 $6.33 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $6.48 Million - $7.61 Million	223,700	223,700 $7.58 Million

1,334

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.